June 19, 2026

Boston Children’s Hospital uses AI to diagnose rare genetic diseases

Families grappling with rare genetic diseases may find hope through innovative AI solutions, as discussed by Hallie Jackson during a live segment featuring Dr. Catherine Brownstein and @_perloj. They highlighted a recent NEJM AI paper detailing how experts at Boston Children’s Hospital utilized o3 Deep Research to enhance the diagnosis of such conditions in children. This effort is part of a broader trend in which advanced AI tools are being implemented in medical settings to tackle previously unsolvable genetic cases, integrating genetic data with clinical insights to aid in the diagnosis of complex pediatric disorders.

_perloj: Jared Perlo, known as @_perloj on X, is an NBC News reporter specializing in AI and technology topics with a background in policy and research. He recently participated in a live discussion alongside Hallie Jackson and Dr. Catherine Brownstein. Perlo contributed to coverage of the NEJM AI paper and Boston Children’s Hospital’s work applying AI to rare disease diagnosis.
Hallie Jackson: Hallie Jackson is a senior Washington correspondent and anchor for NBC News, known for her work on network and streaming platforms covering national news and policy. She recently conducted a live interview discussing advancements in AI for medical diagnostics. Jackson spoke with experts about a new study from Boston Children’s Hospital on using AI to help diagnose rare genetic diseases in children.
Catherine Brownstein: Dr. Catherine Brownstein serves as an assistant professor at Harvard Medical School and project manager at Boston Children’s Hospital, where she focuses on genetic research and rare diseases. She recently contributed to a study published in NEJM AI exploring the use of advanced AI models for clinical diagnostics. Brownstein participated in an NBC News interview about the hospital’s AI-assisted efforts to resolve undiagnosed cases in children.
Boston Children’s Hospital: Boston Children’s Hospital is a leading pediatric academic medical center affiliated with Harvard Medical School and focused on advancing care for children through research and innovation. It maintains specialized programs in rare disease research, including genetic diagnostics. The hospital recently partnered on a study using advanced AI tools to assist clinicians in identifying causes of previously undiagnosed rare genetic diseases in pediatric patients, as detailed in a new NEJM AI publication.

`json
{
“AI in Medicine”: “Advanced AI research tools are being utilized in academic medical settings to revisit unsolved genetic cases and provide new insights for families.”,
“Media Coverage”: “NBC News featured live segments highlighting AI’s role in diagnosing rare diseases at children’s hospitals.”,
“Research Collaboration”: “Boston Children’s Hospital has collaborated with AI developers on projects integrating genetic data, clinical notes, and literature analysis for diagnosing complex pediatric conditions.”
}
`

AI tools built by Emerald Force

Built and supported by Emerald Force.

You might also like